Show Summary Details
Page of

Dystonia: Part 2 

Dystonia: Part 2
Dystonia: Part 2

Paul E. Greene

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 16 April 2021

Despite clinical and genetic clues, the pathophysiology of dystonia is poorly known. The basal ganglia have long been implicated as involved in the production of dystonia, but more recently other areas of the brain, including the cerebellum, have emerged as possibly being involved in producing this complex symptom. Only a few of the diseases causing dystonia are treatable, but the symptoms may be treatable even if the cause is not. Medications are quite effective in children with dystonia, including anticholinergics, baclofen, and benzodiazepines. Surprisingly, both dopaminergic and antidopaminergic medications may sometimes be effective in treating dystonia. Injections of botulinum toxin that weaken muscles are effective in reducing symptoms when the dystonia primarily affects a small number of muscles. When all else fails, deep brain stimulation and a variety of muscle- and nerve-cutting operations have been used with some success in treating dystonic symptoms.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.